Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial
Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page no longer displays a banner about a site outage or the intermittent delays notice, removing visible communication about ongoing service issues. This changes how users perceive the site's availability when viewing the study details.SummaryDifference0.1%

- Check27 days agoChange DetectedAn outage notice is now displayed across the site, warning of intermittent delays in NCBI services. The page revision has been updated to version v3.6.5, replacing the previous v3.6.4.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor site maintenance update and does not alter study information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.3, indicating a newer page version. This reflects a deployment or maintenance update rather than changes to study details.SummaryDifference0.1%

- Check85 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A recruitment status update ('No longer looking for participants') indicates enrollment has closed, the page was updated to Revision: v3.6.0, and minor formatting changes were applied to the Intervention/Treatment label.SummaryDifference0.5%

- Check92 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5. This reflects a routine CMS update and does not change the visible content.SummaryDifference0.1%

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.